CMS has proposed changes that could make prior authorization for certain drugs faster and more electronic for people in Medicare Advantage, Medicaid managed care, CHIP, and Marketplace plans. The rule is still only proposed, and details can change after public comment closes on June 15, 2026.
The FDA is moving to narrow when compounders can make semaglutide, tirzepatide, and liraglutide as national shortages improve. For people using compounded GLP-1 medicines, the practical next step is to check exactly what product they have and confirm any changes with a clinician or pharmacist.
CMS has started rolling out the Rural Health Transformation Program, a $50 billion effort meant to help states strengthen rural care. The first-year awards are in place, but patients should expect changes to arrive unevenly and gradually, not all at once.
B. Braun has recalled two lots of Lactated Ringer’s Injection, 1L, after FDA-posted company testing found particulate matter in the solution. The recall applies to hospitals and healthcare facilities, so patients, caregivers, pharmacists, and clinicians should check lot numbers and follow recall instructions rather than making treatment changes on their own.
CDC says U.S. measles activity is still ongoing, and the main risk is not random exposure but close contact in places where vaccination rates are low. Families, schools, child care sites, shelters, and workplaces can reduce risk by checking immunity, acting quickly after exposure, and watching for early symptoms.
CDC’s updated adult RSV guidance says many older adults should get one RSV vaccine dose before fall respiratory season. For people 75 and older, and for adults 50 to 74 at higher risk, the key questions are when to plan vaccination and what to expect afterward.
CMS began enforcing updated hospital price-transparency requirements on April 1, 2026. Hospitals still must post machine-readable files and consumer-friendly prices, but the new rule is meant to make the data more complete and easier to compare. The catch: patients may still find the information uneven and hard to use.
A routine dental exam can sometimes spot suspicious mouth changes before they cause pain or other symptoms. But oral cancer screening has limits, so adults should know what it can do, who is at higher risk, and when a finding needs more testing.
Federal health agencies are embracing artificial intelligence, but they are pairing that adoption with caution. The practical message for patients and caregivers is simple: AI may be part of care, but the safety and usefulness of any tool depend on the specific device, setting, and oversight behind it.
A short outage can be more than an inconvenience for households that depend on electricity for medical devices, refrigerated medicines, cooling, or food safety. The safest time to prepare is before the lights go out, especially before hot weather and storm season.
Usually not. CDC says antibiotics do not work for seasonal allergies, and many sinus infections get better without them too. Here is how to spot a likely allergy pattern, what may help more, and when fever, severe pain, or breathing symptoms should be checked by a clinician.
A new April 2026 CMS proposal could eventually speed some prescription prior authorization decisions for Medicare Advantage, Medicaid, CHIP, and certain HealthCare.gov plans, but the rule is not final and most coverage will not change right away.
Some babies ages 6 to 11 months can get an early MMR dose during an outbreak or before international travel. Babies under 6 months are too young for MMR, and an early dose does not replace the routine series.
The CDC says the moringa-linked Salmonella outbreak tied to recalled greens supplements is over, but some products may still be in homes because of their long shelf life. Here is what to check, what symptoms to watch for, and why greens powders are not a substitute for a healthy eating pattern.
The American College of Physicians now says routine mammograms can start at 50 for average-risk women, but current federal task force guidance still says start at 40. Here is what changed on April 17, 2026, who is affected, and what questions to ask before your next screening.
A new U.S. trial found that a structured, team-based program at community health centers lowered blood pressure more than enhanced usual care for low-income adults with uncontrolled hypertension. Here is what the study found, what it does not prove, and what readers can do now.
Not much right away for most patients in 2026. CMS has proposed extending many prior-authorization rules to prescription drugs, but the biggest changes would not begin until October 1, 2027 if the rule is finalized, and public drug prior-authorization reporting would generally start in 2028 using 2027 data.
Not automatically. FDA’s March and April 2026 actions say adding B12 or using telehealth does not by itself keep compounded semaglutide available or appropriate. What matters is the prescription, the pharmacy pathway, and whether a prescriber documented a real patient-specific need.
For most people, no-cost vaccine coverage has not disappeared after the March 16, 2026 court ruling over ACIP. But because many U.S. coverage rules still depend on ACIP and CDC recommendations, the appeal could matter for future updates.
The FDA says rare but severe itching has been reported after stopping long-term daily cetirizine or levocetirizine, the drugs sold as Zyrtec, Xyzal, and many generics. Here is how to recognize the pattern, what it is not, and when to ask for medical help.
If your 2026 Marketplace notice says your ACA subsidy changed or your plan may end, do not ignore it. The first step is to figure out what kind of problem the notice describes: overlapping Medicaid or CHIP coverage, missing tax reconciliation, missing verification documents, or a plan you did not authorize.
The FDA has proposed withdrawing Tavneos, but it has not ordered an immediate recall. For patients with ANCA-associated vasculitis, the key step right now is to contact the prescribing specialist before stopping, switching, or delaying treatment.
End of content
End of content
